Fresenius SE & Co. KGaA



Fresenius - the health care group

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.

The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius KabiFresenius Helios and Fresenius Vamed.

Latest news

Fresenius Medical Care and Joslin Diabetes Center Partner to Improve Health of Patients with Diabetic Kidney Disease

Fresenius Medical Care AG & Co. KGaA (the “company” or “Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS) and Joslin Diabetes Center, Inc., the world's preeminent diabetes research, clinical care and education organization, announced an agreement today to jointly develop renal care programs in select Joslin Affiliated Centers for patients with diabetic kidney disease (DKD).

Fresenius Medical Care sets new long-term revenue target - Company outlines vision for 2020 at Capital Markets Day 2014

Fresenius Medical Care hosted a Capital Markets Day on April 3 in New York. The event was aimed at giving analysts and investors further insight into Fresenius Medical Care’s vision for 2020 and the growth and efficiency strategies the company is pursuing

Initial conversion price of equity-neutral convertible bonds fixed

Fresenius has fixed the initial conversion price of the equity-neutral convertible bonds placed on March 18, 2014.

Fresenius successfully places equity-neutral convertible bonds

Fresenius successfully placed €500 million equity-neutral convertible bonds due 2019.

Fresenius announces issuance of equity-neutral convertible bonds

Fresenius intends to issue €375 million equity-neutral convertible bonds due 2019.